Sherbrooke Park Advisers LLC Harmony Biosciences Holdings, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $215 Billion
- Q3 2025
A detailed history of Sherbrooke Park Advisers LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 8,693 shares of HRMY stock, worth $295,822. This represents 0.11% of its overall portfolio holdings.
Number of Shares
8,693
Previous 12,719
31.65%
Holding current value
$295,822
Previous $402 Million
40.39%
% of portfolio
0.11%
Previous 0.17%
Shares
3 transactions
Others Institutions Holding HRMY
# of Institutions
317Shares Held
43.9MCall Options Held
1.05MPut Options Held
310K-
Black Rock Inc. New York, NY5.84MShares$199 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$173 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.69MShares$57.6 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO1.67MShares$56.8 Million0.02% of portfolio
-
State Street Corp Boston, MA1.65MShares$56.3 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.01B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...